Terms: = Skin cancer AND DROSHA, HSA242976, 29102, RNASEN, ENSG00000113360, Q9NRR4, RNASE3L, RN3, RANSE3L, Etohi2
9 results:
1. XPO5 promotes primary miRNA processing independently of RanGTP.
Wang J; Lee JE; Riemondy K; Yu Y; Marquez SM; Lai EC; Yi R
Nat Commun; 2020 Apr; 11(1):1845. PubMed ID: 32296071
[TBL] [Abstract] [Full Text] [Related]
2. CD95/Fas ligand mRNA is toxic to cells.
Putzbach W; Haluck-Kangas A; Gao QQ; Sarshad AA; Bartom ET; Stults A; Qadir AS; Hafner M; Peter ME
Elife; 2018 Oct; 7():. PubMed ID: 30324908
[TBL] [Abstract] [Full Text] [Related]
3. Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism.
Putzbach W; Gao QQ; Patel M; van Dongen S; Haluck-Kangas A; Sarshad AA; Bartom ET; Kim KA; Scholtens DM; Hafner M; Zhao JC; Murmann AE; Peter ME
Elife; 2017 Oct; 6():. PubMed ID: 29063830
[TBL] [Abstract] [Full Text] [Related]
4. Overexpression of drosha, DiGeorge syndrome critical region gene 8 (DGCR8), and Dicer mRNAs in the pathogenesis of psoriasis.
Rostami Mogaddam M; Safavi Ardabili N; Shafaeei Y; Maleki N; Jafari N; Jafari A
J Cosmet Dermatol; 2017 Dec; 16(4):e48-e53. PubMed ID: 28342199
[TBL] [Abstract] [Full Text] [Related]
5. DDX3X promotes the biogenesis of a subset of miRNAs and the potential roles they played in cancer development.
Zhao L; Mao Y; Zhao Y; He Y
Sci Rep; 2016 Sep; 6():32739. PubMed ID: 27586307
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.
Nemlich Y; Greenberg E; Ortenberg R; Besser MJ; Barshack I; Jacob-Hirsch J; Jacoby E; Eyal E; Rivkin L; Prieto VG; Chakravarti N; Duncan LM; Kallenberg DM; Galun E; Bennett DC; Amariglio N; Bar-Eli M; Schachter J; Rechavi G; Markel G
J Clin Invest; 2013 Jun; 123(6):2703-18. PubMed ID: 23728176
[TBL] [Abstract] [Full Text] [Related]
7. Expression of the RNase III enzyme drosha is reduced during progression of human cutaneous melanoma.
Jafarnejad SM; Sjoestroem C; Martinka M; Li G
Mod Pathol; 2013 Jul; 26(7):902-10. PubMed ID: 23370771
[TBL] [Abstract] [Full Text] [Related]
8. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.
Sand M; Skrygan M; Georgas D; Sand D; Gambichler T; Altmeyer P; Bechara FG
Cell Tissue Res; 2012 Oct; 350(1):119-26. PubMed ID: 22706980
[TBL] [Abstract] [Full Text] [Related]
9. Expression levels of the microRNA processing enzymes drosha and dicer in epithelial skin cancer.
Sand M; Gambichler T; Skrygan M; Sand D; Scola N; Altmeyer P; Bechara FG
Cancer Invest; 2010 Jul; 28(6):649-53. PubMed ID: 20210522
[TBL] [Abstract] [Full Text] [Related]
